药品知识产权国际保护的中庸之道  

The Doctrine of the Mean in International Protection of Pharmaceutical Intellectual Property

作　　者：彭立静[1] 

机构地区：[1]中南大学政治学与行政管理学院,湖南长沙410081

出　　处：《中国医学伦理学》2008年第6期26-29,共4页Chinese Medical Ethics

摘　　要：药品知识产权国际保护中存在着多重权利冲突,其中最为突出的就是专利权与生命健康权的对立。试从伦理的角度来审视药品知识产权,以中庸之道来解决药品知识产权国际保护中的权利冲突与道德困境。一方面,作为私权与财产权的药品专利权并没有与更优于它的其他权利发生冲突时,应该保护药品专利权并努力促使这一权利得以实现;另一方面,当药品专利权与位阶上更优于它的生命健康权相冲突时,专利权应让位与生命健康权,作出必要的自我牺牲。在具体实践中,药品知识产权国际保护应尊重差别原则,建立相应的专利药品价格差别制度,高扬救死扶伤的人道精神以维护生命健康权。There are multiple rights conflicts in the international protections of pharmaceutical intellectual property, among which the most prominent is the confrontation of the patent right and the right of life and health. This article tries to examine the pharmaceutical intellectual property rights with an ethical perspective, and resolve the conflict and moral dilemma in its international protection using the doctrine of the mean. When the pharmaceutical patent which is serviced as privacy and property rights, doesn＇t conflict with other more important rights, we should protect pharmaceutical patent and try our best to promote the attainment of it. Otherwise, the patent right should be replaced by the right of life and health. In practice, the international protection of pharmaceutical intellectual property should respect the difference principle, establish the appropriate price different system of pharmaceutical patent and carry forward humanism to safeguard the right of life and health.

关 键 词：药品知识产权 药品专利权 中庸之道 生命健康权 公共健康权 

分 类 号：R954[医药卫生—药学]